Immediate Impact
56 standout
Citing Papers
Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK
2025 Standout
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Works of Christopher Jakubowski being referenced
A phase I/II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab in relapsed/refractory solid tumors with expansions in MSS colorectal cancer.
2020
Colorectal Cancer in the Young: Epidemiology, Prevention, Management
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher Jakubowski | 198 | 200 | 193 | 209 | 19 | 680 | |
| Ty R. Shockley | 92 | 242 | 124 | 443 | 27 | 833 | |
| Yao‐Peng Hsieh | 85 | 113 | 88 | 254 | 31 | 696 | |
| Wendy Chang | 98 | 162 | 46 | 185 | 26 | 668 | |
| Morton Kleiner | 96 | 120 | 138 | 316 | 21 | 778 | |
| Adrienne Melck | 103 | 193 | 64 | 86 | 31 | 690 | |
| Jackie McDonald | 115 | 39 | 166 | 175 | 15 | 757 | |
| Murad Melhem | 81 | 156 | 218 | 126 | 35 | 585 | |
| Ping-Min Chen | 236 | 47 | 97 | 184 | 18 | 822 | |
| Katie Quinn | 172 | 65 | 172 | 117 | 33 | 634 | |
| Johan K. Hiralall | 50 | 216 | 119 | 437 | 20 | 680 |
All Works
Login with ORCID to disown or claim papers
Loading papers...